InsiderTrades.com logo

RGLS Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 4.35%
Insider Buying (Last 12 Months): $171,166.60
Insider Selling (Last 12 Months): $282,237.48

Regulus Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Regulus Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Regulus Therapeutics Share Price & Price History

Current Price: $8.16
Price Change: +0.30 (1.20%)
As of 06/25/2025 01:00 AM ET

This chart shows the closing price history over time for RGLS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Regulus Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/3/2025Preston KlassenInsiderBuy12,000$7.99$95,880.0048,055View SEC Filing Icon  
1/30/2025David BaltimoreDirectorBuy19,610$1.06$20,786.6022,169View SEC Filing Icon  
1/30/2025Joseph P. HaganCEOBuy50,000$1.09$54,500.00260,808View SEC Filing Icon  
1/13/2025Christopher Ray AkerVPSell38,547$1.26$48,569.2254,634View SEC Filing Icon  
1/13/2025Crispina CalsadaCFOSell38,716$1.26$48,782.1650,566View SEC Filing Icon  
1/13/2025Joseph P. HaganCEOSell115,290$1.26$145,265.40222,572View SEC Filing Icon  
1/13/2025Preston KlassenInsiderSell31,445$1.26$39,620.7036,055View SEC Filing Icon  
7/25/2024Kathryn J. CollierDirectorBuy4,000$1.82$7,280.006,740View SEC Filing Icon  
1/18/2024Crispina CalsadaCFOSell5,468$1.19$6,506.925,782View SEC Filing Icon  
1/18/2024Joseph P. HaganCEOSell14,580$1.19$17,350.2057,112View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Regulus Therapeutics (NASDAQ:RGLS)

92.38% of Regulus Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RGLS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Regulus Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/27/2025Goldman Sachs Group Inc.130,339$0.23M0.0%-38.6%0.188%Search for SEC Filing on Google Icon
6/18/2025Voya Investment Management LLC21,368$37K0.0%-7.4%0.031%Search for SEC Filing on Google Icon
5/29/2025Rhumbline Advisers57,744$0.10M0.0%-3.0%0.083%Search for SEC Filing on Google Icon
5/16/2025Octagon Capital Advisors LP4,637,076$8.12M0.9%-4.4%6.698%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.130,339$0.23M0.0%-38.6%0.188%Search for SEC Filing on Google Icon
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.38,345$67K0.0%+4.5%0.055%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC68,580$0.12M0.0%N/A0.099%Search for SEC Filing on Google Icon
5/16/2025Alyeska Investment Group L.P.937,500$1.64M0.0%-9.6%1.354%Search for SEC Filing on Google Icon
5/15/2025Baker BROS. Advisors LP2,694,044$4.72M0.1%N/A4.067%Search for SEC Filing on Google Icon
5/15/2025DAFNA Capital Management LLC847,176$1.48M0.4%-3.2%1.279%Search for SEC Filing on Google Icon
5/15/2025Velan Capital Investment Management LP80,000$0.14M0.1%+14.3%0.121%Search for SEC Filing on Google Icon
5/15/2025Driehaus Capital Management LLC958,345$1.68M0.0%N/A1.447%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC85,602$0.15M0.0%N/A0.129%Search for SEC Filing on Google Icon
5/12/2025Vivo Capital LLC2,696,426$4.72M0.6%-46.1%4.071%Search for SEC Filing on Google Icon
5/8/2025Federated Hermes Inc.15,819,863$27.69M0.1%+23.1%23.882%Search for SEC Filing on Google Icon
5/2/2025Victory Capital Management Inc.386,666$0.68M0.0%-0.8%0.584%Search for SEC Filing on Google Icon
4/23/2025Tyche Wealth Partners LLC121,589$0.21M0.0%+14.6%0.184%Search for SEC Filing on Google Icon
4/23/2025Oppenheimer & Co. Inc.55,000$96K0.0%N/A0.083%Search for SEC Filing on Google Icon
2/17/2025Velan Capital Investment Management LP70,000$0.11M0.1%N/A0.107%Search for SEC Filing on Google Icon
2/17/2025Octagon Capital Advisors LP4,848,802$7.66M1.3%+13.7%7.403%Search for SEC Filing on Google Icon
2/17/2025Millennium Management LLC2,192,158$3.46M0.0%+69.7%3.347%Search for SEC Filing on Google Icon
2/17/2025DAFNA Capital Management LLC875,200$1.38M0.4%-2.2%1.336%Search for SEC Filing on Google Icon
2/14/2025RA Capital Management L.P.336,843$0.53M0.0%-56.1%0.514%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp457,233$0.72M0.0%-8.1%0.698%Search for SEC Filing on Google Icon
2/14/2025Price T Rowe Associates Inc. MD29,597$47K0.0%-98.6%0.045%Search for SEC Filing on Google Icon
2/13/2025PEAK6 LLC60,000$95K0.0%N/A0.092%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC96,247$0.15M0.0%+13.9%0.147%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC117,100$0.19M0.0%+20.5%0.179%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.190,457$0.30M0.0%+141.2%0.291%Search for SEC Filing on Google Icon
2/6/2025Victory Capital Management Inc.389,886$0.62M0.0%-2.3%0.595%Search for SEC Filing on Google Icon
1/30/2025Rhumbline Advisers59,531$94K0.0%-20.1%0.091%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.78,972$0.12M0.0%+193.4%0.121%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC84,477$0.13M0.0%+285.2%0.129%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,280,567$2.01M0.0%-4.0%1.955%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC84,477$0.13M0.0%+285.2%0.129%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC29,580$46K0.0%N/A0.045%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,000,998$1.57M0.0%+3.5%1.528%Search for SEC Filing on Google Icon
11/15/2024RA Capital Management L.P.766,834$1.20M0.0%-87.7%1.171%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.893,762$1.40M0.0%N/A1.365%Search for SEC Filing on Google Icon
11/14/2024NEA Management Company LLC6,467,802$10.15M0.6%N/A9.875%Search for SEC Filing on Google Icon
11/13/2024FMR LLC328,157$0.52M0.0%-83.8%0.501%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company129,700$0.20M0.0%N/A0.198%Search for SEC Filing on Google Icon
11/5/2024Victory Capital Management Inc.398,866$0.63M0.0%+10.4%0.609%Search for SEC Filing on Google Icon
10/25/2024Tyche Wealth Partners LLC106,089$0.17M0.0%+920.6%0.162%Search for SEC Filing on Google Icon
10/11/2024Creative Planning16,466$26K0.0%N/A0.025%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC20,800$33K0.0%N/A0.032%Search for SEC Filing on Google Icon
8/15/2024CVI Holdings LLC401,012$0.72M0.6%-71.5%0.613%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC118,100$0.21M0.0%+56.4%0.180%Search for SEC Filing on Google Icon
8/5/2024Victory Capital Management Inc.361,386$0.65M0.0%-1.8%0.552%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers76,472$0.14M0.0%N/A0.117%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp197,193$0.35M0.0%N/A0.301%Search for SEC Filing on Google Icon
5/29/2024Opaleye Management Inc.170,308$0.49M0.1%N/A0.260%Search for SEC Filing on Google Icon
5/17/2024RA Capital Management L.P.6,250,000$18M0.2%N/A9.547%Search for SEC Filing on Google Icon
5/15/2024NEA Management Company LLC6,467,802$18.63M1.1%N/A9.879%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.740,215$2.13M0.0%+158.4%1.131%Search for SEC Filing on Google Icon
5/7/2024CVI Holdings LLC1,406,250$4.05M3.9%N/A2.148%Search for SEC Filing on Google Icon
4/22/2024Vivo Capital LLC5,000,000$14.40M1.1%N/A7.638%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.271,736$0.35M0.0%+16.5%1.344%Search for SEC Filing on Google Icon
11/13/2023FMR LLC2,922,600$4.03M0.0%+32.4%14.454%Search for SEC Filing on Google Icon
11/6/2023Victory Capital Management Inc.233,207$0.32M0.0%+5.3%1.197%Search for SEC Filing on Google Icon
8/14/2023Prelude Capital Management LLC40,660$60K0.0%N/A0.209%Search for SEC Filing on Google Icon
9/16/2022Federated Hermes Inc.2,904,826$6.01M0.0%-90.0%19.850%Search for SEC Filing on Google Icon
8/16/2022DAFNA Capital Management LLC555,555$1.15M0.3%-90.0%3.797%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC105,341$0.22M0.0%-91.8%0.722%Search for SEC Filing on Google Icon
8/1/2022Victory Capital Management Inc.221,506$0.46M0.0%-90.1%1.517%Search for SEC Filing on Google Icon
7/19/2022Commonwealth Equity Services LLC22,000$45K0.0%-83.2%0.151%Search for SEC Filing on Google Icon
2/14/2022DAFNA Capital Management LLC5,555,555$1.75M0.4%N/A6.382%Search for SEC Filing on Google Icon
1/19/2022Asymmetry Capital Management L.P.2,731,044$0.86M0.5%+94.9%3.137%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP64,708$45K0.0%-68.6%0.074%Search for SEC Filing on Google Icon
11/4/2021Asymmetry Capital Management L.P.1,401,491$0.97M0.6%-3.4%1.610%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC111,000$76K0.0%+38.8%0.128%Search for SEC Filing on Google Icon
8/16/2021State Street Corp176,494$0.14M0.0%N/A0.203%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Regulus Therapeutics logo
Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Read More on Regulus Therapeutics

Today's Range

Now: $8.16
Low: $8.16
High: $8.16

50 Day Range

MA: $8.10
Low: $7.87
High: $8.30

52 Week Range

Now: $8.16
Low: $0.83
High: $8.35

Volume

N/A

Average Volume

1,018,158 shs

Market Capitalization

$564.92 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.35

Who are the company insiders with the largest holdings of Regulus Therapeutics?

Regulus Therapeutics' top insider investors include:
  1. Joseph P Hagan (CEO)
  2. Christopher Ray Aker (VP)
  3. Crispina Calsada (CFO)
  4. Preston Klassen (Insider)
  5. David Baltimore (Director)
  6. Kathryn J Collier (Director)
Learn More about top insider investors at Regulus Therapeutics.